📊 Statistics
- Analyst 1 Year Price Target:
$1.16
- Upside/Downside from Analyst Target:
15.10%
- Broker Call:
6
- Dividend Minimum 3 Year Yield:
2.31%
- EPS Growth Range (1Y):
0-10%
- Net Income Growth Range (1Y):
0-10%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2026-02-23
💰 Dividend History
Current year to date yield:
2.40%
📅 SGX Earnings Announcements for BSL
Raffles Medical Group Ltd (BSL)
Market: SGX |
Currency: SGD
Address: 585 North Bridge Road
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. Its Raffles Hospital, a tertiary care hospital that offers 24-hour acute and critical care, family medicine services, health screening, and a range of multi-disciplinary specialist clinics; appointed wards, day surgery, angiography suites, delivery suites, operating theatres, intensive care unit, and neonatal intensive care unit; and radiology, clinical laboratory, pharmacy, dietetics, rehabilitation, and traditional Chinese medicine, as well as dental services and emergency services. The company also trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. In addition, it engages in the operation of medical clinics and other general medical services; provides specialized medical services; operation of medical laboratory and imaging center; and provision of health insurance products, as well as investment holding activities in investment properties. The company was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
Show more
📈 Raffles Medical Group Ltd Historical Chart
🧾 Recent Financial Statement Analysis
📰 Related News & Research
Showing results matched by any of: BSL, Raffles Medical Group Ltd, Raffles Medical, RFMD SP, RAFFLES MEDICAL GROUP LTD, RAFFLES MEDICAL GROUP
January 5, 2026
Broker Name: CGS International Date of Report: January 5, 2026 Excerpt from CGS International report. Report Summary Raffles Medical Group (RFMD) maintains a strong net cash position, enabling shareholder returns through share buybacks and potential special dividends, especially for its…
July 29, 2025
CGS International July 29, 2025 Raffles Medical Group: Incremental Growth, China Expansion, and Peer Analysis – A Deep Dive into Asia’s Healthcare Leaders Overview: Modest Growth Amid Insurance Headwinds Raffles Medical Group (RMG) continues to demonstrate steady organic growth, reporting…
June 27, 2025
Wall Street banks may be on the cusp of a massive windfall as the U.S. Federal Reserve proposes a major revision to capital rules. Analysts estimate the change could unlock as much as US$6 trillion in balance sheet capacity and…
April 26, 2025
Maybank Research Pte Ltd April 23, 2025 Raffles Medical Group: Strong Immunity – Strategic Shanghai Collaboration Drives Target Price Increase Executive Summary Raffles Medical Group (RFMD SP) has recently forged a strategic agreement with an affiliate of Shanghai Jiao Tong…
April 16, 2025
CGS International Securities Pte. Ltd. April 16, 2025 Trendspotter: Raffles Medical Group Ltd - Uptrend in an Early Stage The global market experienced significant fluctuations as President Donald Trump's evolving tariff war with major trade partners showed little signs of…
September 2, 2024
Wilmar International Ltd (WIL SP) - Benefiting from Higher Swine Prices and Stronger Currencies Recommendation: ADD Target Price: S$3.64 Stop Loss: None specified Date of Recommendation: 30th August 2024 Broker: CGS-CIMB Securities Investment Thesis: Wilmar International Ltd, a leading agribusiness…